AAAAAA
Results: 1-25/102
Authors:
GONZALEZ H
LEBLOND V
AZAR N
SUTTON L
GABARRE J
BINET JL
VERNANT JP
DIGHIERO G
Citation: H. Gonzalez et al., SEVERE AUTOIMMUNE HEMOLYTIC-ANEMIA IN 8 PATIENTS TREATED WITH FLUDARABINE, HEM CELL TH, 40(3), 1998, pp. 113-118
Authors:
RENAUD M
LANGLADEDEMOYEN P
AUTRAN B
LEBLOND V
Citation: M. Renaud et al., EVALUATION OF THE PROTECTIVE EFFECT OF HUMAN CYTOTOXIC LYMPHOCYTES (CTL) SPECIFIC FOR P210(BCR-ABL) PROTEIN IN A SCID MOUSE MODEL, HEM CELL TH, 40(2), 1998, pp. 87-87
Authors:
MOLLET L
SADATSOWTI B
DUNTZE J
LEBLOND V
BERGERON F
CALVEZ V
KATLAMA C
DEBRE P
AUTRAN B
Citation: L. Mollet et al., CD8(HI-LYMPHOCYTES ARE ENRICHED IN ANTIGEN-SPECIFIC T-CELLS CAPABLE OF DOWN-MODULATING CYTOTOXIC ACTIVITY()CD57(+) T), International immunology, 10(3), 1998, pp. 311-323
Authors:
SUTTON L
MALOUM K
GONZALEZ H
ZOUABI H
AZAR N
BOCCACCIO C
CHARLOTTE F
COSSET JM
GABARRE J
LEBLOND V
MERLEBERAL H
BINET JL
Citation: L. Sutton et al., AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION AS SALVAGE TREATMENT FOR ADVANCED B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, Leukemia, 12(11), 1998, pp. 1699-1707
Authors:
ALBIN N
BEMBA M
GABARRE J
SUTTON L
LEBLOND V
Citation: N. Albin et al., INTENSIVE THERAPY FOR NON-HODGKIN-LYMPHOM A - INDICATIONS AND MODALITIES, La Presse medicale, 27(20), 1998, pp. 977-985
Authors:
LEBLOND V
DAVI F
CHARLOTTE F
DORENT R
BITKER MO
SUTTON L
GANDJBAKHCH I
BINET JL
RAPHAEL M
Citation: V. Leblond et al., POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS NOT ASSOCIATED WITH EPSTEIN-BARR-VIRUS - A DISTINCT ENTITY, Journal of clinical oncology, 16(6), 1998, pp. 2052-2059
Authors:
LEBLOND V
BENOTHMAN T
DECONINCK E
TAKSIN AL
HAROUSSEAU JL
DELGADO MA
DELMER A
MALOISEL F
MARIETTE X
MOREL P
CLAUVEL JP
DUBOISSET P
ENTEZAM S
HERMINE O
MERLET M
YAKOUBAGHA I
GUIBON O
CASPARD H
FORT N
Citation: V. Leblond et al., ACTIVITY OF FLUDARABINE IN PREVIOUSLY TREATED WALDENSTROMS-MACROGLOBULINEMIA - A REPORT OF 71 CASES, Journal of clinical oncology, 16(6), 1998, pp. 2060-2064
Authors:
SUTTON L
MALOUM K
COSSET JM
BOCCACCIO C
GONZALEZ H
AZAR N
LEBLOND V
BINET JL
Citation: L. Sutton et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) AS SALVAGE TREATMENT FOR ADVANCED B-CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL), Bone marrow transplantation, 21, 1998, pp. 270-270
Authors:
BOCCACCIO C
BEAUJEAN F
KUENTZ M
RIO B
BELANGER C
BUZYN A
SUTTON L
LEBLOND V
VERNANT JP
Citation: C. Boccaccio et al., USE OF CRYOPRESERVED BONE-MARROW IN ALLOGENEIC TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 324-324
Authors:
ZOUABI H
TURPIN JC
LEONARD C
LEBLOND V
BABINET J
BINET JL
SUTTON L
Citation: H. Zouabi et al., INCREASE OF ARYL SULFATASE-A (ASA) LEVELS DESPITE PARTIAL CHIMERISM AFTER URD BMT FOR METACHROMATIC LEUKODYSTROPHY (MLD), Bone marrow transplantation, 21, 1998, pp. 447-447
Authors:
BRICE P
DIVINE M
COIFFIER B
LEBLOND V
SIMON M
DEVIDAS A
SIMON D
ROHRLICH P
FERME C
Citation: P. Brice et al., DOUBLE AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) IN REFRACTORY AND EARLY DISSEMINATED RELAPSE FROM HODGKINS-DISEASE (HD) - A PILOT-STUDY FROM THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE/, Bone marrow transplantation, 21, 1998, pp. 573-573
Authors:
MOREAU P
LEBLOND V
BOURQUELOT P
FACON T
ATTAL M
CAILLOT D
AUDHUY B
NEDELLEC G
HUYNH A
FERRANT A
BATAILLE R
HAROUSSEAU JL
Citation: P. Moreau et al., PROGNOSTIC FACTORS FOR SURVIVAL AND RESPONSE AFTER HIGH-DOSE THERAPY (HDT) AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR SYSTEMIC AMYLOIDOSIS (AL) - A REPORT ON 22 CASES, Bone marrow transplantation, 21, 1998, pp. 713-713
Authors:
BELKACEMI Y
PENE F
TOUBOUL E
RIO B
LEBLOND V
GORIN NC
LAUGIER A
GEMICI C
HOUSSET M
OZSAHIN M
Citation: Y. Belkacemi et al., TOTAL-BODY IRRADIATION BEFORE BONE-MARROW TRANSPLANTATION FOR ACUTE-LEUKEMIA IN FIRST OR 2ND COMPLETE REMISSION - RESULTS AND PROGNOSTIC FACTORS IN 326 CONSECUTIVE PATIENTS, Strahlentherapie und Onkologie, 174(2), 1998, pp. 92-104
Authors:
SAADA V
ARACTINGI S
LEBLOND V
MARINHO E
FRANCES C
CHOSIDOW O
Citation: V. Saada et al., NEUTROPHILIC ECCRINE HYDRADENTITIS DEVELO PING CONCOMITTANTLY WITH ACUTE MYELOGENOUS LEUKEMIA RELAPSE, Annales de dermatologie et de venereologie, 125(6-7), 1998, pp. 420-422
Authors:
YOTNDA P
FIRAT H
GARCIAPONS F
GARCIA Z
GOURRU G
VERNANT JP
LEMONNIER FA
LEBLOND V
LANGLADEDEMOYEN P
Citation: P. Yotnda et al., CYTOTOXIC T-CELL RESPONSE AGAINST THE CHIMERIC P210 BCR-ABL PROTEIN IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA, The Journal of clinical investigation, 101(10), 1998, pp. 2290-2296
Authors:
ARCHIMBAUD E
FENAUX P
DOMBRET H
DREYFUS F
TILLY H
CONYMAKHOUL P
LEBLOND V
TROUSSARD X
DELAIR S
FFRENCH M
MARIE JP
Citation: E. Archimbaud et al., GM-CSF TO INCREASE EFFICACY OF SEQUENTIAL CHEMOTHERAPY IN PREVIOUSLY TREATED ACUTE MYELOID-LEUKEMIA (AML) - FINAL RESULTS OF A MULTICENTER RANDOMIZED TRIAL (EMA91), British Journal of Haematology, 102(1), 1998, pp. 151-151
Authors:
MOREAU P
LEBLOND V
BOURQUELOT P
FACON T
HUYNH A
CAILLOT D
HERMINE O
ATTAL M
HAMIDOU M
NEDELLEC G
FERRANT A
AUDHUY B
BATAILLE R
MILPIED N
HAROUSSEAU JL
Citation: P. Moreau et al., PROGNOSTIC FACTORS FOR SURVIVAL AND RESPONSE AFTER HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION IN SYSTEMIC AL AMYLOIDOSIS - A REPORT ON 21 PATIENTS, British Journal of Haematology, 101(4), 1998, pp. 766-769
Authors:
FERMAND JP
RAVAUD P
CHEVRET S
DIVINE M
LEBLOND V
BELANGER C
MACRO M
PERTUISET E
DREYFUS F
MARIETTE X
BOCCACIO C
BROUET JC
Citation: Jp. Fermand et al., HIGH-DOSE THERAPY AND AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA - UP-FRONT OR RESCUE TREATMENT - RESULTS OFA MULTICENTER SEQUENTIAL RANDOMIZED CLINICAL-TRIAL, Blood, 92(9), 1998, pp. 3131-3136
Authors:
BENKERROU M
JAIS JP
LEBLOND V
DURANDY A
SUTTON L
BORDIGONI P
GARNIER JL
LEBIDOIS J
LEDEIST F
BLANCHE S
FISCHER A
Citation: M. Benkerrou et al., ANTI-B-CELL MONOCLONAL-ANTIBODY TREATMENT OF SEVERE POSTTRANSPLANT B-LYMPHOPROLIFERATIVE DISORDER - PROGNOSTIC FACTORS AND LONG-TERM OUTCOME, Blood, 92(9), 1998, pp. 3137-3147
Authors:
CARRERAS E
BERTZ H
ARCESE W
VERNANT JP
TOMAS JF
HAGGLUND H
BANDINI G
ESPEROU H
RUSSELL J
DELARUBIA J
DIGIROLAMO G
DEMUYNCK H
HARTMANN O
CLAUSEN J
RUUTU T
LEBLOND V
IRIONDO A
BOSI A
BENBASSAT I
KOZA V
GRATWOHL A
APPERLEY JF
Citation: E. Carreras et al., INCIDENCE AND OUTCOME OF HEPATIC VENOOCCLUSIVE DISEASE AFTER BLOOD ORMARROW TRANSPLANTATION - A PROSPECTIVE COHORT STUDY OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION, Blood, 92(10), 1998, pp. 3599-3604
Authors:
AMOURA Z
LEBLOND V
AZAR N
MONTALESCOT G
BAGNIS C
SCHMIDT J
DEGENNES C
WECHSLER B
BOCCACCIO C
GODEAU P
PIETTE JC
Citation: Z. Amoura et al., HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FORSYSTEMIC AMYLOIDOSIS (AL) - REPORT OF 9 CASES, Arthritis and rheumatism, 41(9), 1998, pp. 1207-1207
Authors:
BORNANDROUSSELOT A
SAINTJEAN O
LEBLOND V
Citation: A. Bornandrousselot et al., SEQUENTIAL CHLORAMBUCIL AND PREDNISONE AS 2ND-LINE THERAPY IN GASTRICMALT LYMPHOMA RESISTANT TO HELICOBACTER-PYLORI ERADICATION - A CASE-REPORT IN AN OCTOGENARIAN PATIENT, Journal of the American Geriatrics Society, 46(2), 1998, pp. 253-254
Authors:
LEBLOND V
AUTRAN B
CESBRON JY
Citation: V. Leblond et al., THE SCID MOUSE MUTANT - DEFINITION AND POTENTIAL USE AS A MODEL FOR IMMUNE AND HEMATOLOGICAL DISORDERS, HEM CELL TH, 39(5), 1997, pp. 213-221
Authors:
AUTRAN B
MALPHETTES M
DHEDIN N
GOROCHOV G
LEBLOND V
DEBRE P
Citation: B. Autran et al., STUDIES OF T-CELL RECONSTITUTION AFTER HEMATOPOIETIC STEM-CELL TRANSPLANT, HEM CELL TH, 39(5), 1997, pp. 252-256
Authors:
SUTTON L
LEBLOND V
RIBAUD P
JOUET JP
Citation: L. Sutton et al., INDICATIONS AND TIMING OF ALLOGENEIC BONE-MARROW TRANSPLANTATION IN MYELODYSPLASTIC SYNDROMES, Leukemia & lymphoma, 27(5-6), 1997, pp. 475-485